PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-157

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    The FDA have just approved iPPS in its injectable form for the retired NFL player trial. That fact is already a big win. The steps taken to get that initial trial approval isn't a walk in the park, so it's a positive foot in the door for mine.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.